Related Experiment Videos
Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA
1Department of Veterans Affairs Medical Center, Iowa City, IA 52246, USA. arthur-krieg@uiowa.edu
Immunology Today
|November 9, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Immunostimulatory CpG motifs and DNA vaccines.
Methods in molecular medicine·2011
DNA-based immune enhancers.
Current opinion in drug discovery & development·2009
The CpG motif: implications for clinical immunology.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy·2007
Enhancement of infectious disease vaccines through TLR9-dependent recognition of CpG DNA.
Current topics in microbiology and immunology·2006
The origin and significance of anti-DNA antibodies.
Immunology today·2014
Mutations of class II MHC molecules.
Immunology today·2014
Antigen processing at the molecular level.
Immunology today·2014
Phenotypically and functionally distinct T-cell subsets in anti-tumor responses.
Immunology today·2014
Are MHC class II-restricted cytotoxic T lymphocytes important?
Immunology today·2014
Complement and the regulation of humoral immune responses.
Immunology today·2014
Regulatory T cells in intracerebral hemorrhage: mechanisms of immunomodulation and therapeutic potential.
Frontiers in immunology·2026
Fc-engineering for improved cancer immunotherapy.
Biochemical Society transactions·2026
Explosive Multiterritorial Arterial Thrombosis Following Brief Heparin Exposure: A Diagnostic Pitfall in the Cath Lab.
Case reports in cardiology·2026
Lipophilic Ligand Efficiency-Monitored Discovery of Potent, Achiral, and Bioavailable Apo-IDO1 Inhibitors.
ACS medicinal chemistry letters·2026
Telitacicept for IgA nephropathy: a systematic review and meta-analysis of observational studies.
Frontiers in medicine·2026
Envafolimab - novel anti-PD-1/PD-L1 antibody in cancer treatment.
Frontiers in immunology·2026